Sign in Pull a receipt

KRSA

Korsana Biosciences, Inc.

Healthcare · Biotechnology

$192.66 sample

+2.70 (+1.42%) 1D

Market cap

$291.3B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-23

Alerts

8

Price$192.66 -10.67% 3M daily closessample

218.11186.17

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider sell: EVP, Operations
Oct 16INSInsider sell: EVP, Operations
Oct 07INSInsider sell: Director
Oct 01INSInsider buy: 10% owner
Sep 23SEC10-Q filed
Sep 17INSInsider sell: EVP, Operations
Sep 14INSInsider buy: General Counsel
Sep 09INSInsider sell: EVP, Operations

Sign up to see the real KRSA record →

Company facts

SEC EDGAR registration

Name: Korsana Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -42sample, -100 to +100
Reporting currency: USD

Who is positioning in KRSA

sample

Insiders: 16 insider transactions over 90 days, net selling, $373.4M
Congress: 5 members traded over 90 days
Institutions · 13F: 22 funds hold $3.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$16.6B +15.4% y/y

Q4 2024Q3 2026

Inventory$9.8B +8.8% y/y

Q4 2024Q3 2026

Accounts receivable$7.3B +12.7% y/y

Q4 2024Q3 2026

Total debt$19.6B +15.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $50.5B -12.7% 3M
Sample peer B: $235.3B +0.4% 3M
Sample peer C: $32.2B +10.4% 3M
Sample peer D: $212.0B -11.5% 3M
Sample peer E: $199.5B +0.8% 3M